Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China

被引:4
|
作者
Wu, Ziwei [1 ,2 ,3 ,6 ]
Chen, Ziyi [4 ]
Long, Siyu [1 ,6 ]
Wu, Aiping [3 ,4 ]
Wang, Hongsheng [1 ,5 ,6 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing 210042, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Dept Hlth Toxicol, Nanjing 211166, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China
[4] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Nanjing, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Jiangsu Key Lab Mol & Biol Skin Dis & STIs, Nanjing, Peoples R China
关键词
COVID-19; Intervention; Tuberculosis; Incidence; Model; TARGETS; TREND;
D O I
10.1186/s12879-022-07620-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The COVID-19 pandemic has driven public health intervention strategies, including keeping social distance, wearing masks in crowded places, and having good health habits, to prevent the transmission of the novel coronavirus (SARS-CoV-2). However, it is unknown whether the use of these intervention strategies influences morbidity in other human infectious diseases, such as tuberculosis. Methods In this study, three prediction models were constructed to compare variations in PTB incidences after January 2020 without or with intervention includes strict and regular interventions, when the COVID-19 outbreak began in China. The non-interventional model was developed with an autoregressive integrated moving average (ARIMA) model that was trained with the monthly incidence of PTB in China from January 2005 to December 2019. The interventional model was established using an ARIMA model with a continuing intervention function that was trained with the monthly PTB incidence in China from January 2020 to December 2020. Results Starting with the assumption that no COVID-19 outbreak had occurred in China, PTB incidence was predicted, and then the actual incidence was compared with the predicted incidence. A remarkable overall decline in PTB incidence from January 2020 to December 2020 was observed, which was likely due to the potential influence of intervention policies for COVID-19. If the same intervention strategy is applied for the next 2 years, the monthly PTB incidence would reduce on average by about 1.03 per 100,000 people each month compared with the incidence predicted by the non-interventional model. The annual incidence estimated 59.15 under regular intervention per 100,000 in 2021, and the value would decline to 50.65 with strict interventions. Conclusions Our models quantified the potential knock-on effect on PTB incidence of the intervention strategy used to control the transmission of COVID-19 in China. Combined with the feasibility of the strategies, these results suggested that continuous regular interventions would play important roles in the future prevention and control of PTB.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China
    Ziwei Wu
    Ziyi Chen
    Siyu Long
    Aiping Wu
    Hongsheng Wang
    [J]. BMC Infectious Diseases, 22
  • [2] Guideline for regular epidemic prevention and control of COVID-19 for civil airports in China
    Capital Airports Holding Company (CAH)
    Beijing Capital International Airport Hospital
    Hubei Airports Group Company
    First Aid Station of Hubei Wuhan Tianhe International Airport
    Heilongjiang Airports Management Group Co.
    Ltd.
    Emergency Center of Fire Department of Heilongjiang Airports Management Group Co.
    [J]. 中华航空航天医学杂志, 2020, 31 (02) : 80 - 100
  • [3] The impact of the COVID-19 epidemic on tuberculosis control in China
    Fei, Huang
    Xia Yinyin
    Hui, Chen
    Ni, Wang
    Du Xin
    Wei, Chen
    Li Tao
    Huan Shitong
    Sun Miaomiao
    Chen Mingting
    Keshavjee, Salmaan
    Zhao Yanlin
    Chin, Daniel P.
    Liu Jianjun
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2020, 3
  • [4] The model of epidemic (COVID-19) prevention and control in rural of China
    Fu, Bao
    Fu, Xiaoyun
    [J]. CRITICAL CARE, 2020, 24 (01):
  • [5] The model of epidemic (COVID-19) prevention and control in rural of China
    Bao Fu
    Xiaoyun Fu
    [J]. Critical Care, 24
  • [6] Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19
    Chen, Bizhen
    Wang, Meiling
    Huang, Xun
    Xie, Maokun
    Pan, Liting
    Liu, Huiwen
    Liu, Zhenguo
    Zhou, Pengcheng
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [7] Epidemiological Investigation: Important Measures for the Prevention and Control of COVID-19 Epidemic in China
    Zhu, Cheng-Cheng
    Zhu, Jiang
    Shao, Jie
    [J]. MATHEMATICS, 2023, 11 (13)
  • [8] Control and Prevention of the COVID-19 Epidemic in China: A Qualitative Community Case Study
    Wu, Yijin
    Zhang, Quan
    Li, Linzi
    Li, Meiyu
    Zuo, Ying
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2021, 14 : 4907 - 4922
  • [9] Tenure of office, political rotation and the prevention and control of the COVID-19 epidemic in China
    Huang, Jiawen
    Huang, Yeqing
    Wu, Kaize
    [J]. JOURNAL OF CHINESE GOVERNANCE, 2023, 8 (01) : 134 - 159